A SerucellBio Inc. Platform Science Resource

intelligentcellsignaling.com

Biology is a conversation
between cells.

Not a metaphor. A literal biochemical fact. Every tissue function — repair, regeneration, structural maintenance, inflammation resolution — is downstream of what cells signal to each other. When that conversation is intact, tissue maintains itself. When it degrades, tissue fails. At every scale. In every organ.

Scroll to explore the platform ↓

Cell-to-cell communication is not a feature of biology. It is the operating system.

Every cell in every tissue exists within a signaling environment. Keratinocytes receive instructions from fibroblasts below them. Alveolar epithelium coordinates with lung fibroblasts. No cell operates in isolation. No cell was designed to.

This is not incidental to tissue function. It is the mechanism by which tissue function is coordinated, maintained, and restored. When the conversation between cell populations degrades — through senescence, fibrosis, cycling arrest, or environmental damage — the tissue it governs begins to fail. Not because a component broke. Because the instructions stopped arriving.

This distinction is fundamental. It determines what kind of intervention can actually restore tissue behavior — and what kind cannot.

Intercellular Signaling — The Governing Layer

Keratinocyte

Paracrine

Fibroblast

Epidermal–Dermal Axis · Skin

Alveolar Epithelium

Paracrine

Lung Fibroblast

Alveolar–Interstitial Axis · Lung

"The signals that govern tissue behavior do not come from individual cells. They emerge from the conversation between them."

Single-target intervention operates below the layer where tissue behavior is actually governed.

The dominant model of biological medicine identifies a molecular target — a gene, a receptor, a transcript — and modulates it. This is powerful when disease is a single-component failure. But tissue failure at the systemic level is not a broken component. It is a communication breakdown. And no single-target intervention can restore a conversation.

Single-Target BiologyCell Communication Biology
Unit of analysisIndividual cellCell population in dialogue
MechanismBlock, degrade, or activate one targetRestore the signaling environment
AssumptionDisease = broken componentDisease = communication breakdown
InterventionPrecision moleculeEngineered multi-cell secretome
OutputChanged protein activityChanged tissue behavior
PlatformMonoculture-derivedCo-culture emergent

"Monoculture science studies a conversation by listening to one speaker in a soundproof room. The message is partial. The biology is not."

This is not a criticism of precision pharmacology. It is a description of the biological layer it cannot access. The emergent secretome — the signals that only appear when multiple cell populations communicate — exists at an altitude above what any single-cell approach can reach.

A SerucellBio Technology

Multi-cellular co-culture engineered for emergent signaling.

The Intelligent Cell Signaling platform co-cultures multiple human cell lines simultaneously under controlled conditions. The secretome it produces is not the sum of what individual cell types generate in isolation. It is what emerges when those populations are in active biochemical dialogue — signals, growth factors, cytokines, and vesicle cargo that no monoculture can produce.

This is not an optimization of existing secretome technology. It is access to a different biological layer entirely.

The Emergence Finding
385

proteins

detected exclusively in co-culture — absent from all single-cell conditions

Approximately 40% of the co-culture proteome appeared only when keratinocyte and fibroblast populations were in active communication. These proteins were not present in keratinocyte monoculture. They were not present in fibroblast monoculture. They emerged from the conversation between them.

"This is not addition. It is emergence."

Regulated Signal Environment

Mass spectrometry data from the co-culture research shows both upregulated and downregulated proteins relative to single-cell output. The platform does not stimulate indiscriminately. It produces a coordinated signal state — consistent with a regulated communication environment, not blunt activation.

60%+

proteins show positive variance in co-culture vs. single-cell sum

The secretome is not a byproduct of cell culture. It is the product of a controlled biological event.

A conventional conditioned-media process grows cells and collects the medium. Intelligent Cell Signaling treats the secretome as the output of a designed biological state — a defined, tissue-mimetic repair signal rather than generic cell behavior.

The co-culture production methodology is protected by a portfolio of five granted US patents. The specific process architecture that produces this emergent signaling is proprietary to SerucellBio Inc. and is not disclosed publicly.

The same platform logic. Two independent tissue systems.

The platform has been applied to two independent tissue communication axes — skin and lung. Each represents a distinct cell population, a distinct disease context, and a distinct therapeutic goal. The underlying operating principle is identical. Both tissue systems were produced under the same platform discipline. The tissue changes. The production architecture does not.

Skin Axis — Restoration

Keratinocyte × Fibroblast

Epidermal-Dermal Junction Paracrine Signaling Secretome Biology
Communication Failure

Dermal fibroblast senescence disrupts the epidermal-dermal paracrine axis. Senescent fibroblasts shift from regenerative secretion to pro-inflammatory SASP output — IL-6, IL-8, MMP enzymes — that degrades the matrix and corrupts the signal keratinocytes depend on. The conversation changes character. From instruction to noise.

Platform Output

KFS® — Human Keratinocyte Fibroblast Saline Conditioned Media. INCI-registered. Deployed commercially through Serucell Skincare Inc.

Clinical Stage

Randomized pilot study, radiation dermatitis indication. IRB approved — Marshall University IRBNet 1977269-1. Principal Investigator: Sanjeev Sharma, MD. Marshall Health Network.

Lung Axis — Normalization

Alveolar × Interstitial

Alveolar-Interstitial Axis Anti-Fibrotic Signaling Preclinical
Communication Failure

In idiopathic pulmonary fibrosis, healthy intercellular signaling between alveolar epithelium and fibroblasts is replaced by pro-fibrotic communication. TGF-β driven myofibroblast conversion accelerates. Periostin accumulates. Complement dysregulation propagates. The tissue loses its normal signaling character and progressively scars.

Platform Output

LEO — a co-culture secretome directed at the alveolar-interstitial axis, produced under the Intelligent Cell Signaling platform. Composition, formulation, and route of administration are not disclosed.

Preclinical Stage

LEO has been evaluated in an independent preclinical model. Findings are not disclosed at this stage.

Independent third-party preclinical evaluation.

"Two organs. Two disease contexts. Two independent cell populations. One platform logic. The tissue changes. The principle does not."

The skin axis and the lung axis were developed independently, from different cell sources, targeting different disease endpoints. The emergent secretome logic that governs both is Intelligent Cell Signaling. This is what organ-agnostic means.

The published science underlying this field.

The following peer-reviewed publications represent foundational and current research on intercellular signaling, cellular senescence, secretome biology, and pulmonary fibrosis. These are sources from the scientific literature — not product claims or clinical assertions.

01

Recent advances in dermal fibroblast senescence and skin aging: unraveling mechanisms and pioneering therapeutic strategies.

Zhang et al., Zhejiang University. Frontiers in Pharmacology, June 2025. PMC12213903.

02

Lifespan, Healthspan, and the Expanding Role of Cosmetic Dermatology in Longevity Science.

Haykal D, Flament F, Othman K, Siow R. Journal of Cosmetic Dermatology, 2025. PMC12703656.

03

Translating Geroscience Into Clinical Longevity Dermatology: From Mechanisms of Aging to Skin-Centered Interventions.

Haykal D et al. Journal of Cosmetic Dermatology, 2026.

04

Cellular Senescence in Human Skin Aging: Leveraging Senotherapeutics.

PMC, 2024. PMC10873061.

05

Dermal Fibroblast Senescence: The Central Hub of Skin Aging — From Intrinsic Dysfunction to Microenvironmental Remodeling.

International Journal of Molecular Sciences, 2026. MDPI.

06

Fibroblast-to-Myofibroblast Transition in Idiopathic Pulmonary Fibrosis: The Role of Paracrine Signaling and the Extracellular Matrix.

Current literature — IPF secretome biology.

07

Senescence-Associated Secretory Phenotype (SASP) in Pulmonary Fibrosis: Mechanisms and Therapeutic Targets.

Current literature — SASP and fibrosis.

08

Organism-Wide, Cell-Type-Specific Secretome Mapping.

Cell Metabolism, 2023.

09

Dynamic Tracking and Identification of Tissue-Specific Secretory Proteins In Vivo.

Nature Communications, 2021.

10

Autophagy Orchestrates the Crosstalk Between Cells and Organs.

EMBO Reports, 2023.

11

Stress-Primed Secretory Autophagy Promotes Extracellular BDNF Maturation.

Nature Communications, 2021.

12

Secretome of Aged Fibroblasts Alters Keratinocyte Behavior.

Journal of Investigative Dermatology, 2021.

13

Senescence Induces Fundamental Changes in the Secretome of MSCs.

PMC10203235, 2023.

14

The Senescence-Associated Secretory Phenotype (SASP).

Nature Reviews Molecular Cell Biology, 2024.

This research library is curated for scientific context only. All citations are from peer-reviewed literature. Content on this site does not constitute medical advice, clinical claims, or product efficacy statements. Intelligent Cell Signaling is a scientific platform education resource operated by SerucellBio Inc.